• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流感病毒血凝素与其小分子配体相互作用的理论研究。

Theoretical studies of the interaction between influenza virus hemagglutinin and its small molecule ligands.

机构信息

State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, Key Laboratory of Natural Pesticides and Chemical Biology, South China Agricultural University, Guangzhou, 510642, China.

出版信息

J Mol Model. 2013 Dec;19(12):5561-8. doi: 10.1007/s00894-013-2036-0. Epub 2013 Nov 21.

DOI:10.1007/s00894-013-2036-0
PMID:24253319
Abstract

Hemagglutinin (HA) is a membrane protein present on the influenza viral envelope. It is responsible for molecular recognition between the viral particle and the host cell, as well as fusion of the viral envelope to the endosome bilayer. Because it is essential for influenza viral infection and replication, it has become a target for the design of anti-influenza drugs. Previous studies have identified two small molecule HA ligands (CL-385319 and 1L) that inhibit infection with pseudovirus H5N1 with different potency. In order to compare their different inhibitory activities and shed light on drug design targeting the HA protein, we conducted a variety of theoretical calculations, including docking, molecular dynamics simulations, free energy calculations, as well as quantum calculations to investigate interactions between these two ligands and the HA protein. We found that molecule 1L has stronger π-π interactions with the side chains of residues F110₂ and M24₁ compared with molecule CL-385319. We propose that these stronger π-π interactions are responsible for the higher inhibitory activity of molecule 1L. Our calculations will aid drug design studies targeting the HA protein.

摘要

血凝素 (HA) 是存在于流感病毒包膜上的一种膜蛋白。它负责病毒粒子与宿主细胞之间的分子识别,以及病毒包膜与内体双层膜的融合。由于它是流感病毒感染和复制所必需的,因此它已成为设计抗流感药物的目标。先前的研究已经确定了两种小分子 HA 配体 (CL-385319 和 1L),它们以不同的效力抑制假型 H5N1 感染。为了比较它们不同的抑制活性,并阐明针对 HA 蛋白的药物设计,我们进行了各种理论计算,包括对接、分子动力学模拟、自由能计算以及量子计算,以研究这两种配体与 HA 蛋白之间的相互作用。我们发现分子 1L 与残基 F110₂和 M24₁的侧链之间具有更强的 π-π 相互作用,而分子 CL-385319 则没有。我们提出这些更强的 π-π 相互作用是分子 1L 具有更高抑制活性的原因。我们的计算将有助于针对 HA 蛋白的药物设计研究。

相似文献

1
Theoretical studies of the interaction between influenza virus hemagglutinin and its small molecule ligands.流感病毒血凝素与其小分子配体相互作用的理论研究。
J Mol Model. 2013 Dec;19(12):5561-8. doi: 10.1007/s00894-013-2036-0. Epub 2013 Nov 21.
2
An induced pocket for the binding of potent fusion inhibitor CL-385319 with H5N1 influenza virus hemagglutinin.一个诱导口袋,用于结合强效融合抑制剂 CL-385319 与 H5N1 流感病毒血凝素。
PLoS One. 2012;7(8):e41956. doi: 10.1371/journal.pone.0041956. Epub 2012 Aug 2.
3
Design, synthesis and structure-activity relationship of novel inhibitors against H5N1 hemagglutinin-mediated membrane fusion.新型 H5N1 血凝素介导的膜融合抑制剂的设计、合成与构效关系研究。
Eur J Med Chem. 2012 Nov;57:211-6. doi: 10.1016/j.ejmech.2012.08.041. Epub 2012 Sep 7.
4
CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry.CL-385319 通过阻断病毒进入来抑制 H5N1 禽流感病毒感染。
Eur J Pharmacol. 2011 Jun 25;660(2-3):460-7. doi: 10.1016/j.ejphar.2011.04.013. Epub 2011 Apr 22.
5
Oligothiophene compounds inhibit the membrane fusion between H5N1 avian influenza virus and the endosome of host cell.寡聚噻吩类化合物抑制 H5N1 禽流感病毒与宿主细胞内体之间的膜融合。
Eur J Med Chem. 2017 Apr 21;130:185-194. doi: 10.1016/j.ejmech.2017.02.040. Epub 2017 Feb 21.
6
New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.针对血凝素介导的流感 A 病毒融合的新型小分子进入抑制剂。
J Virol. 2014 Feb;88(3):1447-60. doi: 10.1128/JVI.01225-13. Epub 2013 Nov 6.
7
Selection of an antiviral RNA aptamer against hemagglutinin of the subtype H5 avian influenza virus.抗 H5 亚型禽流感病毒血凝素的抗病毒 RNA 适体的筛选。
Nucleic Acid Ther. 2011 Dec;21(6):395-402. doi: 10.1089/nat.2011.0321. Epub 2011 Oct 21.
8
Molecular dynamics simulation of the effects of single (S221P) and double (S221P and K216E) mutations in the hemagglutinin protein of influenza A H5N1 virus: a study on host receptor specificity.甲型H5N1流感病毒血凝素蛋白单突变(S221P)和双突变(S221P与K216E)影响的分子动力学模拟:宿主受体特异性研究
J Biomol Struct Dyn. 2016 Sep;34(9):2054-67. doi: 10.1080/07391102.2015.1106341. Epub 2015 Nov 26.
9
An oligothiophene compound neutralized influenza A viruses by interfering with hemagglutinin.一种寡聚噻吩化合物通过干扰血凝素中和了甲型流感病毒。
Biochim Biophys Acta Biomembr. 2018 Mar;1860(3):784-791. doi: 10.1016/j.bbamem.2017.12.006. Epub 2017 Dec 8.
10
Structure of avian influenza hemagglutinin in complex with a small molecule entry inhibitor.禽流感血凝素与小分子进入抑制剂复合物的结构。
Life Sci Alliance. 2020 Jul 1;3(8). doi: 10.26508/lsa.202000724. Print 2020 Aug.

引用本文的文献

1
Insights into structural and inhibitory mechanisms of low pH-induced conformational change of influenza HA2 protein: a computational approach.流感HA2蛋白低pH诱导构象变化的结构与抑制机制洞察:一种计算方法
J Mol Model. 2019 Mar 23;25(4):99. doi: 10.1007/s00894-019-3982-y.

本文引用的文献

1
Design, synthesis and structure-activity relationship of novel inhibitors against H5N1 hemagglutinin-mediated membrane fusion.新型 H5N1 血凝素介导的膜融合抑制剂的设计、合成与构效关系研究。
Eur J Med Chem. 2012 Nov;57:211-6. doi: 10.1016/j.ejmech.2012.08.041. Epub 2012 Sep 7.
2
An induced pocket for the binding of potent fusion inhibitor CL-385319 with H5N1 influenza virus hemagglutinin.一个诱导口袋,用于结合强效融合抑制剂 CL-385319 与 H5N1 流感病毒血凝素。
PLoS One. 2012;7(8):e41956. doi: 10.1371/journal.pone.0041956. Epub 2012 Aug 2.
3
Free-energy simulations reveal that both hydrophobic and polar interactions are important for influenza hemagglutinin antibody binding.
自由能模拟揭示,疏水性和极性相互作用对于流感血凝素抗体结合都很重要。
Biophys J. 2012 Mar 21;102(6):1453-61. doi: 10.1016/j.bpj.2012.01.043. Epub 2012 Mar 20.
4
Aromatic rings in chemical and biological recognition: energetics and structures.化学和生物识别中的芳环:能量学和结构。
Angew Chem Int Ed Engl. 2011 May 16;50(21):4808-42. doi: 10.1002/anie.201007560. Epub 2011 Apr 28.
5
CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry.CL-385319 通过阻断病毒进入来抑制 H5N1 禽流感病毒感染。
Eur J Pharmacol. 2011 Jun 25;660(2-3):460-7. doi: 10.1016/j.ejphar.2011.04.013. Epub 2011 Apr 22.
6
Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations.评估 MM/PBSA 和 MM/GBSA 方法的性能。1. 基于分子动力学模拟的结合自由能计算的准确性。
J Chem Inf Model. 2011 Jan 24;51(1):69-82. doi: 10.1021/ci100275a. Epub 2010 Nov 30.
7
Improved side-chain torsion potentials for the Amber ff99SB protein force field.改进的 Amber ff99SB 蛋白质力场的侧链扭转势。
Proteins. 2010 Jun;78(8):1950-8. doi: 10.1002/prot.22711.
8
An improved generalized AMBER force field (GAFF) for urea.改进的通用 AMBER 力场(GAFF)用于尿素。
J Mol Model. 2010 Sep;16(9):1427-40. doi: 10.1007/s00894-010-0650-7. Epub 2010 Feb 17.
9
The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks.血凝素蛋白的激活 pH 值调节 H5N1 流感病毒在鸭子中的致病性和传染性。
J Virol. 2010 Feb;84(3):1527-35. doi: 10.1128/JVI.02069-09. Epub 2009 Nov 18.
10
Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA.使用 MM-PBSA 和 MM-GBSA 快速准确地预测结合自由能。
J Comput Chem. 2010 Mar;31(4):797-810. doi: 10.1002/jcc.21372.